160
Views
25
CrossRef citations to date
0
Altmetric
Review

Targeting the A3 adenosine receptor to treat cytokine release syndrome in cancer immunotherapy

&
Pages 491-497 | Published online: 30 Jan 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Srinath Innani, Yashika Tomar, Vikas Rana & Gautam Singhvi. (2023) Navigating the landscape of psoriasis therapy: novel targeted pathways and emerging trends. Expert Opinion on Therapeutic Targets 0:0, pages 1-10.
Read now
Hemant Murthy, Madiha Iqbal, Julio C Chavez & Mohamed A Kharfan-Dabaja. (2019) Cytokine Release Syndrome: Current Perspectives. ImmunoTargets and Therapy 8, pages 43-52.
Read now
Stefania Merighi, Enrica Battistello, Luca Giacomelli, Katia Varani, Fabrizio Vincenzi, Pier Andrea Borea & Stefania Gessi. (2019) Targeting A3 and A2A adenosine receptors in the fight against cancer. Expert Opinion on Therapeutic Targets 23:8, pages 669-678.
Read now

Articles from other publishers (22)

Dan-Xia Ying, Peng-Cheng Zhao, Wen Zhang & Guo-Wu Rao. (2023) Research Progress in Competitive Purine Antagonists. Current Medicinal Chemistry 30:34, pages 3880-3904.
Crossref
Barbara Kutryb-Zając, Ada Kawecka, Khrystyna Nasadiuk, Alicja Braczko, Klaudia Stawarska, Elisabetta Caiazzo, Patrycja Koszałka & Carla Cicala. (2023) Drugs targeting adenosine signaling pathways: A current view. Biomedicine & Pharmacotherapy 165, pages 115184.
Crossref
Kenneth A. Jacobson, Balaram Pradhan, Zhiwei Wen & Asmita Pramanik. (2023) New paradigms in purinergic receptor ligand discovery. Neuropharmacology 230, pages 109503.
Crossref
Deep Shah, Brian Soper & Lindsay Shopland. (2023) Cytokine release syndrome and cancer immunotherapies – historical challenges and promising futures. Frontiers in Immunology 14.
Crossref
Lip Ket Chin, Jun-Yeong Yang, Benjamin Chousterman, Sunghoon Jung, Do-Geun Kim, Dong-Ho Kim, Seunghun Lee, Cesar M. Castro, Ralph Weissleder, Sung-Gyu Park & Hyungsoon Im. (2023) Dual-Enhanced Plasmonic Biosensing for Point-of-Care Sepsis Detection. ACS Nano 17:4, pages 3610-3619.
Crossref
Haji Akbar, Julia J. Fasick, Nagendraprabhu Ponnuraj & Keith W. Jarosinski. (2023) Purinergic signaling during Marek’s disease in chickens. Scientific Reports 13:1.
Crossref
Kenneth A. Jacobson, Paola Oliva & R. Rama Suresh. 2023.
A. Szczepkowska, J. Bochenek, M. Wójcik, D. Tomaszewska-Zaremba, H. Antushevich, M. Tomczyk, J. Skipor & A. Herman. (2022) Effect of caffeine on adenosine and ryanodine receptor gene expression in the hypothalamus, pituitary, and choroid plexus in ewes under basal and LPS challenge conditions. Journal of Animal and Feed Sciences 32:1, pages 17-25.
Crossref
Zhan-Guo Gao, John A. Auchampach & Kenneth A. Jacobson. (2022) Species dependence of A3 adenosine receptor pharmacology and function. Purinergic Signalling.
Crossref
Gregory S. Whitehead, Tadeusz P. Karcz, Dilip K. Tosh, Young-Hwan Jung, Zhiwei Wen, Ryan G. Campbell, Varun Gopinatth, Zhan-Guo Gao, Kenneth A. Jacobson & Donald N. Cook. (2022) Effects of Purinergic Receptor Deletion or Pharmacologic Modulation on Pulmonary Inflammation in Mice. ACS Pharmacology & Translational Science 5:10, pages 973-984.
Crossref
Kavitha Ramasamy, Jaikumar Shanmugasundaram, Rajesh Manoharan, Viswanathan Subramanian, Parimala Kathirvelu & Rajagopalan Vijayaraghavan. (2022) Anti-neuropathic effect of 7,3′-dihydroxyflavone in paclitaxel induced peripheral neuropathy in mice involving GABAA, KATP channel and adenosine receptors. Neurochemistry International 159, pages 105388.
Crossref
Koji Kuronuma, Mitsuo Otsuka, Masato Wakabayashi, Takeshi Yoshioka, Tomofumi Kobayashi, Masami Kameda, Yasuhide Morioka, Hirofumi Chiba & Hiroki Takahashi. (2022) Role of transient receptor potential vanilloid 4 in therapeutic antifibrotic effects of pirfenidone. American Journal of Physiology-Lung Cellular and Molecular Physiology 323:2, pages L193-L205.
Crossref
Anna SuchankovaMargarita Stampelou, Klontiana Koutsouki, Athanasios Pousias, Lakshiv DhingraKerry BarkanNicole Pouli, Panagiotis Marakos, Roxane Tenta, Antonios Kolocouris, Nikolaos Lougiakis & Graham Ladds. (2022) Discovery of a High Affinity Adenosine A 1 /A 3 Receptor Antagonist with a Novel 7-Amino-pyrazolo[3,4- d ]pyridazine Scaffold . ACS Medicinal Chemistry Letters 13:6, pages 923-934.
Crossref
Pnina Fishman. (2022) Drugs Targeting the A3 Adenosine Receptor: Human Clinical Study Data. Molecules 27:12, pages 3680.
Crossref
Shahin Hallaj, Mohammad Mirza-Aghazadeh-Attari, Amin Arasteh, Anahita Ghorbani, Daniel Lee & Farhad Jadidi-Niaragh. (2021) Adenosine: The common target between cancer immunotherapy and glaucoma in the eye. Life Sciences 282, pages 119796.
Crossref
Livio Luongo, Francesca Guida, Sabatino Maione, Kenneth A. Jacobson & Daniela Salvemini. (2021) Adenosine Metabotropic Receptors in Chronic Pain Management. Frontiers in Pharmacology 12.
Crossref
Zhengyu Fang, Sumei Xu, Yiwen Xie & Wenxi Yan. (2021) Identification of a prognostic gene signature of colon cancer using integrated bioinformatics analysis. World Journal of Surgical Oncology 19:1.
Crossref
Ramarao Poduri, Gaurav Joshi & Gowraganahalli Jagadeesh. (2020) Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of Covid-19. Cellular Signalling 74, pages 109721.
Crossref
Kenneth A. Jacobson, Luigino Antonio Giancotti, Filomena Lauro, Fatma Mufti & Daniela Salvemini. (2020) Treatment of chronic neuropathic pain: purine receptor modulation. Pain 161:7, pages 1425-1441.
Crossref
Abdul Rehman, Noor Ul-Ain Baloch, John P. Morrow, Pál Pacher & György Haskó. (2020) Targeting of G-protein coupled receptors in sepsis. Pharmacology & Therapeutics 211, pages 107529.
Crossref
Zhan-Guo Gao & Kenneth A. Jacobson. (2019) A2B Adenosine Receptor and Cancer. International Journal of Molecular Sciences 20:20, pages 5139.
Crossref
Kenneth A. Jacobson, Dilip K. Tosh, Shanu Jain & Zhan-Guo Gao. (2019) Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development. Frontiers in Cellular Neuroscience 13.
Crossref